Effects of botulinum toxin A on the sphincter of Oddi: An in vivo and in vitro study

Gut

Volumn 42, Issue 4, 1998, Pages 507-510

  Sand, J ^a   Nordback, I ^a   Arvola, P ^a   Porsti I ^a   Kalloo, A ^b   Pasricha, P ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Botulinum toxin; Ex vivo; Pig; Sphincter of Oddi

Indexed keywords

ACETYLCHOLINE; ATROPINE; BOTULINUM TOXIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DUODENOSCOPY; ELECTROSTIMULATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SWINE; VATER PAPILLA; VATER PAPILLA STENOSIS;

EID: 0031925363     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.4.507     Document Type: Article

References (35)

1. Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 1981;33:155-88.
2. Blasi J, Chapman ER, Link E, et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993;365:160-3.
3. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.
4. Pasricha PJ, Ravich WJ, Kalloo AN. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastronterology 1993;105:1045-9.
5. Pasricha PJ, Kalloo AN. Botulinum toxin for the treatment of gastrointestinal smooth muscle disorders. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994.
6. Pasricha PJ, Ravich WJ, Kalloo AN. Botulinum toxin for achalasia. Lancet 1993;341:244-5.
7. Pasricha PJ, Ravich WJ, Hendrix TR, et al. Treatment of achalasia with intrasphincteric injection of botulinum toxin: A pilot trial. Ann Intern Med 1994;121:590-1 .
8. Gul D, Cassetta E, Anastasio G, et al. Botulinum toxin for chronic anal fissure. Lancet 1994;344:1127-8.
9. Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994;35:1319-21.
10. Pasricha PJ, Sostre S, Kalloo AN. Endoscopic injection of botulinum toxin for patients with suspected sphincter of Oddi dysfunction: results of a pilot trial [abstract]. Gastrointest Endosc 1994;40:421.
11. Dickson EC, Shevky R. Botulism, studies on the manner in which the toxin of Clostridium botulinum acts upon the body. I. The effect upon the autonomic nervous system. J Exp Med 1923;37:711-31.
12. Bigalke H, Habermann E. Blockade of tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1980;312:255-63.
13. Paul ML, Cook MA. Lack of effect of botulinum toxin on nonadrenergic, noncholinergic inhibitory responses of the guinea-pig fundus in vitro. Can J Physiol Pharmacol 1980;58:88-92.
14. Toouli J, Baker RE. Innervation of the sphincter of Oddi: physiology and considerations of pharmacological intervention in biliary dyskinesia. Pharmacol Ther 1991;49:269-81.
15. Becker JM, Parodi JE. Basic control mechanisms of sphincter of Oddi motor function. Gastrointest Endosc Clin North Am 1993;3:41-66.
16. Makhlouf GM. Smooth muscle of the gut. In: Yamada T, ed. Textbook of Gastroenterology. 1st edn. Philadelphia: JB Lippincott Co., 1991:60.
17. Sand J, Arvola P, Jäntti V, et al. The inhibitory role of nitric oxide in the control of porcine and human sphincter of Oddi activity. Gut 1997;41:375-80.
18. Kyösola K. Cholinesterase histochemistry of the innervation of the smooth muscle sphincters around the terminal intramural parts of the ductus choledochus in the cat and dog. Acta Physiol Scand 1974;90:278-80.
19. Cai W, Gabella G. Innervation of the gall-bladder and biliary pathways in the guinea-pig. J Anat 1983;136:97-109.
20. Helm JF, Venu RP, Geenen JE, et al. Effects of morphine on the human sphincter of Oddi. Gut 1988;29:1402-7.
21. Thune BA, Baker RA, Saccone GTP, et al. Pethidine and morphine have different actions on human sphincter of Oddi motility. Rr J Surg 1990;77:992-5.
22. Toouli J, Dodds WJ, Honda R, et al. Motor function of the opossum sphincter of Oddi. J Clin Invest 1983;71:208-20.
23. Pasricha PJ, Tietjen TG, Kalloo AN. Endoscopic biliary manometry in swine: a unique model for training and research. Endoscopy 1995;27:70-2.
24. Sand J, Tainio H, Nordback I. Neuropeptides in pig sphincter of Oddi, bile duct, gallbladder, and duodenum. Dig Dis Sci 1993;38:694-700.
25. Sand J, Tainio H, Nordback I. Peptidergic innervation of human sphincter of Oddi. Dig Dis Sci 1994;39:293-300.
26. Pitt HA, Doty JE, Roslyn JJ, et al. The role of altered extrahepatic biliary function in the pathogenesis of gallstones after vagotomy. Surgery 1981;90:418-25.
27. Tansy MF, Innes DL, Martin JS, et al. An evaluation of the neural influences on the SO in the dog. Am J Dig Dis 1974; 19:423-37.
28. Takahashi I, Dodds WJ, Hogan WJ, et al. Vagotomy and biliary tract motility in the opossum. Dig Dis Sci 1088;33: 481-9.
29. Allescher HD, Neuhaus H, Hagemuller F, et al. Effect of N-butylscopolamine on sphincter of Oddi motility in patients during routine ERCP a manometric study. Endoscopy 1990;22:160-3.
30. DiSomma C, Reboa G, Patrone MG, et al. Effects of pinaverium bromide on Oddi's sphincter. Clin Ther 1986;9: 119-22.
31. Garrigues V, Ponce J, Pertejo V, et al. Effects of atropine and pirenzipine on sphincter of Oddi motility. A manometric study. J Hepatol 1980;3:247-50.
32. Kobayashi K, Mitani E, Tatsumi S, et al. Studies on papillary function and effect of prifinium bromide and other antispasmodics on motility of the papillary region (sphincter of Oddi) in humans. Clin Ther 1985;7:154-63.
33. Lamazza A, Tofi A, Bolognese A, et al. Effects of pinaverium bromide in the premedication of endoscopic retrograde cholangio-pancreatography and on motor activity in the sphincter of Oddi. Curr Med Res Opin 1986;10:280-4.
34. Meshkinpour H, Mollot M, Eckerling GB, et al. Bile duct dyskinesia. A clinical and manometric study. Gastroenterology 1984;87:759-62.
35. Staritz M. Pharmacology of the sphincter of Oddi. Endoscopy 1988;20(Suppl 1):171-4.